IRIS
METRA, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 23.313
AS - Asia 7.126
NA - Nord America 3.497
SA - Sud America 601
AF - Africa 135
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 34.681
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 17.900
US - Stati Uniti d'America 3.317
SG - Singapore 2.658
CN - Cina 2.562
IT - Italia 2.411
FR - Francia 2.196
HK - Hong Kong 618
VN - Vietnam 590
BR - Brasile 376
IN - India 190
DE - Germania 186
GB - Regno Unito 178
CA - Canada 88
NL - Olanda 79
AR - Argentina 78
BD - Bangladesh 71
IQ - Iraq 68
SE - Svezia 67
FI - Finlandia 54
MX - Messico 52
ES - Italia 48
TR - Turchia 48
JP - Giappone 39
PL - Polonia 39
ZA - Sudafrica 36
PH - Filippine 35
SA - Arabia Saudita 34
CO - Colombia 33
EC - Ecuador 33
ID - Indonesia 27
PK - Pakistan 27
AT - Austria 26
VE - Venezuela 26
DZ - Algeria 24
MY - Malesia 22
CL - Cile 21
JO - Giordania 17
RO - Romania 16
MA - Marocco 15
NP - Nepal 15
KE - Kenya 14
LT - Lituania 14
UA - Ucraina 14
UZ - Uzbekistan 14
MD - Moldavia 13
CH - Svizzera 12
EG - Egitto 12
PY - Paraguay 12
TN - Tunisia 12
AE - Emirati Arabi Uniti 10
IL - Israele 10
PT - Portogallo 10
PE - Perù 9
TH - Thailandia 9
DO - Repubblica Dominicana 7
RS - Serbia 7
AU - Australia 6
AZ - Azerbaigian 6
BO - Bolivia 6
CR - Costa Rica 6
GR - Grecia 6
IE - Irlanda 6
KR - Corea 6
PR - Porto Rico 6
BY - Bielorussia 5
JM - Giamaica 5
OM - Oman 5
SI - Slovenia 5
TW - Taiwan 5
BA - Bosnia-Erzegovina 4
CY - Cipro 4
ET - Etiopia 4
LB - Libano 4
SV - El Salvador 4
UY - Uruguay 4
HR - Croazia 3
HU - Ungheria 3
KG - Kirghizistan 3
KW - Kuwait 3
KZ - Kazakistan 3
LI - Liechtenstein 3
MM - Myanmar 3
SN - Senegal 3
SR - Suriname 3
SY - Repubblica araba siriana 3
BE - Belgio 2
BH - Bahrain 2
CI - Costa d'Avorio 2
GE - Georgia 2
HN - Honduras 2
IR - Iran 2
MU - Mauritius 2
MV - Maldive 2
PA - Panama 2
PS - Palestinian Territory 2
TT - Trinidad e Tobago 2
VI - Stati Uniti Isole Vergini 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
Totale 34.653
Salva come PNG Salva come JPEG
Città #
Moscow 4.068
Lauterbourg 1.761
Ashburn 913
Singapore 686
San Jose 655
Hong Kong 608
Milan 604
Beijing 271
New York 249
Rome 219
Ho Chi Minh City 192
Council Bluffs 168
Santa Clara 167
Orem 166
Hanoi 149
Naples 100
Bologna 97
Dallas 96
Los Angeles 93
Turin 85
Chennai 78
Brescia 69
Catania 62
Frankfurt am Main 58
Nuremberg 57
Figino 56
Shanghai 46
Bari 45
Genoa 43
Manchester 42
São Paulo 40
Hefei 38
Da Nang 37
Lappeenranta 36
Denver 32
Tokyo 32
Palermo 31
Atlanta 29
London 28
Warsaw 28
Baghdad 26
Montreal 25
Paris 25
Florence 24
Haiphong 24
Amsterdam 23
Brooklyn 23
Boardman 22
Mumbai 21
Verona 21
Guangzhou 19
Hangzhou 19
Toronto 18
Brugherio 17
Helsinki 17
Lawrence 17
Princeton 17
Stockholm 17
Amman 16
Chicago 16
Johannesburg 16
Padua 16
Poplar 16
Houston 14
Phoenix 14
Barnet 13
Curitiba 13
Mexico City 13
Modena 13
Tashkent 13
Erbil 12
Parma 12
Quito 12
Biên Hòa 11
Dhaka 11
Kuala Lumpur 11
Lahore 11
Munich 11
Buffalo 10
Charlotte 10
Jeddah 10
Nairobi 10
Rio de Janeiro 10
Seattle 10
Vienna 10
Ankara 9
Bergamo 9
Bogotá 9
Cagliari 9
Lecce 9
New Delhi 9
Santiago 9
Zurich 9
Brasília 8
Cape Town 8
Caserta 8
Changsha 8
Hyderabad 8
Mareno di Piave 8
Phủ Lý 8
Totale 13.071
Salva come PNG Salva come JPEG
Nome #
2-year outcomes of MitraClip as a bridge to heart transplantation: The international MitraBridge registry 150
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up 102
Effect of Chronic Kidney Disease on 5-Year Outcome in Patients With Heart Failure and Secondary Mitral Regurgitation Undergoing Percutaneous MitraClip Insertion 92
Prognostic Value of Pre-operative Atrial Fibrillation in Patients with Secondary Mitral Regurgitation Undergoing MitraClip Implantation 87
MitraClip in secondary mitral regurgitation as a bridge to heart transplantation: 1-year outcomes from the International MitraBridge Registry 82
Transcatheter Edge-To-Edge Repair in COAPT-ineligible Patients: Incidence and Predictors of 2-year Good Outcome 82
Incidence, Predictors, and Prognostic Impact of New Permanent Pacemaker Implantation After TAVR With Self-Expanding Valves 81
Prognostic value of right ventricular longitudinal strain in patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge mitral valve repair 79
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial 78
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 77
Evolution of tricuspid regurgitation after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation and its impact on mortality 75
Concomitant Transcatheter Edge-to-Edge Treatment of Secondary Tricuspid and Mitral Regurgitation: An Expert Opinion 75
Clinical Presentation and Outcome in a Contemporary Cohort of Patients With Acute Myocarditis 74
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era 67
H2FPEF and HFA-PEFF scores performance and the additional value of cardiac structure and function in patients with atrial fibrillation 66
Artificial intelligence-derived risk score for mortality in secondary mitral regurgitation treated by transcatheter edge-to-edge repair: the EuroSMR risk score 62
Atrial Secondary Tricuspid Regurgitation: Insights Into the EuroTR Registry 62
Prevalence and outcome of elderly and low-risk patients with degenerative mitral regurgitation undergoing transcatheter edge-to-edge repair 62
Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology 62
Derivation and Validation of a Clinical Risk Score for COAPT-Ineligible Patients Who Underwent Transcatheter Edge-to-Edge Repair 62
Dynamic cardiomyoplasty as an effective therapy for dilated cardiomyopathy 61
ST-Elevation Myocardial Infarction in Patients With COVID-19: Clinical and Angiographic Outcomes 61
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis 56
2024 update in heart failure 55
Prognostic Impact of Heart Failure History in Patients with Secondary Mitral Regurgitation Treated by MitraClip 53
Centralization of the ST elevation myocardial infarction care network in the Lombardy region during the COVID-19 outbreak 52
Combined evaluation of perfusion and function for the identification of viable myocardium 51
Transcatheter Valve Repair in Heart Failure with Moderate to Severe Mitral Regurgitation 49
THE INTERPLAY BETWEEN CARDIOLOGY AND DIABETOLOGY: A RENEWED COLLABORATION TO OPTIMIZE CARDIOVASCULAR PREVENTION AND HEART FAILURE MANAGEMENT 49
Challenges and future perspectives of transcatheter tricuspid valve interventions: adopt old strategies or adapt to new opportunities? 47
Impact of heart failure severity on the mortality benefit of mitral transcatheter edge-to-edge valve repair 47
Transcatheter treatment of chronic mitral regurgitation with the MitraClip system: an Italian consensus statement 47
Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry 47
Impact of disproportionate secondary mitral regurgitation in patients undergoing edge-to-edge percutaneous mitral valve repair 46
Epidemiology, pathophysiology, diagnosis and management of atrial functional mitral regurgitation: An expert opinion paper 45
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC 45
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1 - epidemiology, pathophysiology, and diagnosis 44
Right Ventricular–Pulmonary Artery Coupling in Tricuspid Regurgitation: Prognostic Value and Impact of Treatment Strategy 44
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9) 44
Moderate Secondary Mitral Regurgitation: Evolving Evidence and Management Strategies 43
The Relevance of Right Ventricular Function and Dimension in Patients Undergoing Transcatheter Tricuspid Edge-to-Edge Repair 43
Long-term changes in left ventricular mass, chamber size and function after valve replacement in patients with severe aortic stenosis and depressed ejection fraction 42
The prognostic value of the Dandel's index in patients undergoing tricuspid transcatheter edge-to-edge repair 41
Emicrania, angina e ipertensione arteriosa; dai beta-bloccanti ai calcioantagonisti. La nicardipina 40
Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of Cardiology 40
Mitral regurgitation evolution after transcatheter tricuspid valve interventions - A sub-analysis of the TriValve registry 40
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC 40
Long-Term Outcomes After Edge-to-Edge Repair of Secondary Mitral Regurgitation: 5-Year Results From the EuroSMR Registry 39
Blood pressure and intensive treatment up-titration after acute heart failure hospitalization: Insights from the STRONG-HF trial 39
2023 Focused update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 39
[Position paper of the Italian Society of Cardiology: The renin-angiotensin-aldosterone system (RAAS) blockade in heart failure patients - Part I: From RAAS identification to clinical trials] 39
Educational needs and application of guidelines in the management of patients with mitral regurgitation. A European mixed-methods study 39
Transcatheter Edge-To-Edge Mitral Valve Repair in Non-COAPT-Like Patients: Incidence and Predictors of 2-Year Good Outcome 38
Therapeutical approach of tricuspid regurgitation and right heart failure 38
Management of acute coronary syndromes during the COVID-19 outbreak in Lombardy: The "macro-hub" experience 38
The impact of time since SARS-Cov-2 vaccination, age, sex and comorbidities on COVID-19 outcome in hospitalized patients with SARS-CoV-2 infection 37
Impact of Pulmonary Hypertension on Outcomes After Transcatheter Tricuspid Valve Edge-to-Edge Repair 37
Assessing aortic flow with doppler echocardiography in cardiogenic shock: A crucial diagnostic tool 37
Acute Heart Failure: Transitioning From Symptom-Based Care to Remission 36
COVID myocarditis: a review of the literature 36
Management of aortic stenosis and chronic heart failure: A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC 36
January 2023 at a glance: focus on acute heart failure and medical therapy 36
Cardiac contractility modulation: an effective treatment strategy for heart failure beyond reduced left ventricular ejection fraction? 36
Burst steroid therapy and quality of life in patients with acute heart failure: Insights from the CORTAHF trial 36
[Heart rate and outcome in patients with acute and chronic heart failure] 36
Heart failure with improved versus persistently reduced left ventricular ejection fraction: A comparison of the BIOSTAT-CHF (European) study with the ASIAN-HF registry 36
Fisiopatologia dello scompenso cardiaco: basi per una razionale strategia terapeutica. Seconda parte: implicazioni terapeutiche 36
Autovalutazione in tema di infarto miocardico I - Fisiopatologia dell'infarto miocardico acuto 36
Multiomics Analysis Provides Novel Pathways Related to Progression of Heart Failure 35
Diuretic De-Escalation in Response to HF Therapy: Are We Closer to Reduced Reliance on Diuretics? 35
Decongestion and Outcomes in Patients Hospitalized for Acute Heart Failure: Insights From the RELAX-AHF-2 Trial 35
I beta bloccanti hanno probabilmente mantenuto le loro promesse prolungando l’aspettativa di vita nei pazienti con scompenso cardiaco. Ma hanno anche migliorato la qualità di vita di questi pazienti? 35
Characteristics and outcomes of patients with tricuspid regurgitation and advanced heart failure 35
Tricuspid Regurgitation Disease Stages and Treatment Outcomes After Transcatheter Tricuspid Valve Repair 35
Malnutrition and outcomes in patients with tricuspid regurgitation undergoing transcatheter tricuspid valve repair 35
[RESHAPE-HF2: new evidence and clinical implications] 35
Differenti risposte agli agenti inotropi dopo terapia betabloccante a lungo termine con metoprololo o carvedilolo in pazienti con insufficienza cardiaca cronica 34
Changes in Liver Function Tests, Congestion, and Prognosis After Acute Heart Failure: The STRONG-HF Trial 34
[Position paper of the Italian Society of Cardiology: The renin-angiotensin-aldosterone system blockade in heart failure patients - Part II: Mechanistic effects of sacubitril/valsartan, placement in current guidelines and use in clinical practice] 34
GLP-1 receptor agonists as promising anti-inflammatory agents in heart failure with preserved ejection fraction 34
Cardiovascular imaging updates and future perspectives 34
The role of multimorbidity in patients with heart failure across the left ventricular ejection fraction spectrum: Data from the Swedish Heart Failure Registry 34
Prevalence, Characteristics and Prognostic Impact of Aortic Valve Disease in Patients with Heart Failure and Reduced, Mildly Reduced, and Preserved Ejection Fraction: An Analysis of the ESC Heart Failure Long-Term Registry 34
Advanced heart failure: guideline-directed medical therapy, diuretics, inotropes, and palliative care 33
Amino acids and derivatives, a new treatment of chronic heart failure? 33
[Italian Society of Cardiology-Italian Society of Nephrology Consensus document: The cardio-renal interaction in the prevention and treatment of cardiovascular diseases - Part I: From cardiovascular risk factors to the mechanisms of cardio-renal syndrome] 33
Asse cuore-rene nell’iperteso cardiopatico 33
Polimorfismi genetici dell’enzima di conversione dell’angiotensina (ACE) e del recettore β2-adrenergico ed insufficienza cardiaca 33
Effect of Omecamtiv Mecarbil on Exercise Capacity in Chronic Heart Failure With Reduced Ejection Fraction: The METEORIC-HF Randomized Clinical Trial 33
Nuovi agenti inotropi. Quali vantaggi rispetto alla digitale? 32
Assessment of the ventilatory response to exercise in patients with heart failure. Correlation with the other parameters of functional capacity and hemodynamic determinants 32
2023 focused update of the 2021 ESC heart failure guidelines: Key messages for clinical practice 32
Se il cuore non basta…L’epidemia dell’insufficienza cardiaca in Occidente interessa 16 milioni di persone – Prevenzione e trattamento 32
Right heart failure and mortality in patients undergoing transcatheter tricuspid valve interventions 32
Diagnostica clinica dello scompenso cardiaco 32
Knowledge and application of ESC/HFA guidelines in the management of advanced heart failure 32
Biologically active adrenomedullin as a marker for residual congestion and early rehospitalization in patients hospitalized for acute heart failure: Data from STRONG-HF 32
Aortopathies: From Etiology to the Role of Arterial Stiffness 32
[Empagliflozin and heart failure: the EMPEROR-Reduced trial] 32
Autovalutazione in tema di infarto miocardico III - Terapia del paziente infartuato 32
Totale 4.697
Salva come PNG Salva come JPEG
Categoria #
all - tutte 111.654
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.654
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202215 2 0 0 3 0 3 2 0 2 0 1 2
2022/2023113 35 16 5 1 3 12 11 12 5 2 2 9
2023/2024134 19 4 12 10 11 13 3 16 0 6 16 24
2024/2025470 42 9 9 19 9 40 57 86 87 51 27 34
2025/202636.752 101 118 119 225 375 5.132 5.447 4.161 18.217 2.857 0 0
Totale 37.498